225 related articles for article (PubMed ID: 29875733)
21. Genome-wide (over)view on the actions of vitamin D.
Carlberg C
Front Physiol; 2014; 5():167. PubMed ID: 24808867
[TBL] [Abstract][Full Text] [Related]
22. ETS transcription factor family member GABPA contributes to vitamin D receptor target gene regulation.
Seuter S; Neme A; Carlberg C
J Steroid Biochem Mol Biol; 2018 Mar; 177():46-52. PubMed ID: 28870774
[TBL] [Abstract][Full Text] [Related]
23. Key Vitamin D Target Genes with Functions in the Immune System.
Koivisto O; Hanel A; Carlberg C
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32325790
[TBL] [Abstract][Full Text] [Related]
24. Primary vitamin D receptor target genes as biomarkers for the vitamin D3 status in the hematopoietic system.
Wilfinger J; Seuter S; Tuomainen TP; Virtanen JK; Voutilainen S; Nurmi T; de Mello VD; Uusitupa M; Carlberg C
J Nutr Biochem; 2014 Aug; 25(8):875-84. PubMed ID: 24854954
[TBL] [Abstract][Full Text] [Related]
25. Modulation of vitamin D signaling by the pioneer factor CEBPA.
Nurminen V; Neme A; Seuter S; Carlberg C
Biochim Biophys Acta Gene Regul Mech; 2019 Jan; 1862(1):96-106. PubMed ID: 30550771
[TBL] [Abstract][Full Text] [Related]
26. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
27. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
28. Vitamin D: A master example of nutrigenomics.
Carlberg C; Raczyk M; Zawrotna N
Redox Biol; 2023 Jun; 62():102695. PubMed ID: 37043983
[TBL] [Abstract][Full Text] [Related]
29. Dissecting high from low responders in a vitamin D3 intervention study.
Saksa N; Neme A; Ryynänen J; Uusitupa M; de Mello VD; Voutilainen S; Nurmi T; Virtanen JK; Tuomainen TP; Carlberg C
J Steroid Biochem Mol Biol; 2015 Apr; 148():275-82. PubMed ID: 25448738
[TBL] [Abstract][Full Text] [Related]
30. Genomic Determinants of Vitamin D-Regulated Gene Expression.
Pike JW; Meyer MB; Benkusky NA; Lee SM; St John H; Carlson A; Onal M; Shamsuzzaman S
Vitam Horm; 2016; 100():21-44. PubMed ID: 26827947
[TBL] [Abstract][Full Text] [Related]
31. Vitamin D receptor signaling and its therapeutic implications: Genome-wide and structural view.
Carlberg C; Molnár F
Can J Physiol Pharmacol; 2015 May; 93(5):311-8. PubMed ID: 25741777
[TBL] [Abstract][Full Text] [Related]
32. Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells.
Pramanik R; Asplin JR; Lindeman C; Favus MJ; Bai S; Coe FL
Cell Immunol; 2004; 232(1-2):137-43. PubMed ID: 15876428
[TBL] [Abstract][Full Text] [Related]
33. The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor.
Dunlop TW; Väisänen S; Frank C; Molnár F; Sinkkonen L; Carlberg C
J Mol Biol; 2005 Jun; 349(2):248-60. PubMed ID: 15890193
[TBL] [Abstract][Full Text] [Related]
34. 1,25-Dihydroxyvitamin D3 regulates the expression of low-density lipoprotein receptor-related protein 5 via deoxyribonucleic acid sequence elements located downstream of the start site of transcription.
Fretz JA; Zella LA; Kim S; Shevde NK; Pike JW
Mol Endocrinol; 2006 Sep; 20(9):2215-30. PubMed ID: 16613987
[TBL] [Abstract][Full Text] [Related]
35. Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3.
Hughes MR; Baylink DJ; Jones PG; Haussler MR
J Clin Invest; 1976 Jul; 58(1):61-70. PubMed ID: 1084355
[TBL] [Abstract][Full Text] [Related]
36. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
Chow EC; Quach HP; Vieth R; Pang KS
Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
[TBL] [Abstract][Full Text] [Related]
37. Linking Mechanisms of Vitamin D Signaling with Multiple Sclerosis.
Carlberg C; Mycko MP
Cells; 2023 Sep; 12(19):. PubMed ID: 37830605
[TBL] [Abstract][Full Text] [Related]
38. The impact of chromatin organization of vitamin D target genes.
Carlberg C; Dunlop TW
Anticancer Res; 2006; 26(4A):2637-45. PubMed ID: 16886674
[TBL] [Abstract][Full Text] [Related]
39. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
Raval-Pandya M; Freedman LP; Li H; Christakos S
Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
[TBL] [Abstract][Full Text] [Related]
40. Characterization of a vitamin D3-resistant MCF-7 cell line.
Narvaez CJ; Vanweelden K; Byrne I; Welsh J
Endocrinology; 1996 Feb; 137(2):400-9. PubMed ID: 8593782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
